The US Specialty Pharmaceutical Market Report: 2015 Edition – New Report by Koncept Analytics

DELHI, India - April 4, 2015 - PRLog -- The key factors driving growth of the US specialty pharmaceutical industry include accelerating US aging population, ameliorating economic condition, increased life expectancy, and increasing healthcare expenditure. Currently, specialty drugs are one of the fastest growing segments of the overall pharmaceutical market, as sales growth is being driven by innovative new drug launches and the relatively high cost of therapy versus traditional drugs. As specialty pharmaceuticals are often breakthrough therapies, they typically see strong sales ramps due to improved efficacy compared with currently marketed therapies, while expanded indications for already marketed drugs and offlabel prescribing can drive sales of these drugs by increasing potential patient populations.

The research report, “The US Specialty Pharmaceuticals Market: 2015 Edition”reveals that the percentage share of specialty pharmaceuticals in overall pharmaceutical market in the US has been tremendously growing as the specialty pharmaceutical and biotech industries have seen an uptick in product approvals over the past few years. Also, it was noticed that growth in specialty sector in 2014 was largely driven by the introduction of new drugs for Hepatitis C. The report also indicated that specialty pipeline for novel therapies continues to be strong which will also provide an incremental growth in coming years.

It elucidates recent developments, product pipeline and encompasses a number of factors driving the growth of the US specialty sector coupled with recent trends and challenges hindering the growth of the market which enables the client to access opportunity areas and have a detailed insight of the US specialty pharmaceutical market.

In the end, detailed competitive scenario of the market along with the profiles of key players is also provided which includes their key financials and business strategies. By deploying SPSS Inc.’s data integration and analysis capabilities, future growth prediction for the period spanning 2014-2017 to determine the future direction of the industry has also been analyzed in the report. Overall, the report is an outcome of in depth research and prudent analysis to offer suitable knowledge base of the industry.

List of Charts

Flow of Products within the Specialty Pharmacy Channel
SP Benefits Model
The US Pharmaceutical Market (2008-TTM2014)
US Monthly Pharmaceutical Sales Growth (January 2013-September 2014)
The US Traditional Pharmaceutical Market (2008-TTM2014)
The US Specialty Pharmaceutical Market (2008-TTM2014)
Percentage Share of Traditional and Specialty Pharmaceutical in the US (2014)
Distributor Specialty Sales by Customer (2014)
Share of Constituents of Specialty Pharmaceutical Market (2014)
Share of Therapeutics in Specialty Pharmacy Market (TTM through 9/2014)
Specialty Drug Spend (2012-2018)
Specialty Drug Spending Trend (2014 – 2018E)
The US Aging Population (2009-2013)
The US Life Expectancy Rate (2009-2014E)
The US Healthcare Expenditure Per Capita (2006-2013)
GNI of the US (2006-2013)
Medicare Enrollments (2006-2013)
Percentage Share of Specialty Drugs in the US – by Revenue (2014E)
Specialty Pharmacy Market Share (2013)
Specialty Distributors Market Share (2014)
Johnson & Johnson’s Revenue Share by Business Segments (2014)
Johnson & Johnson’s Revenues and Net Income (2011-2014)
Johnson & Johnson’s Pharmaceutical Revenues in the US (2012-2014)
Amgen’s Revenue Share by Business segment (2013)
Amgen’s Revenues and Net Income (2008-2013)
Breakdown by Business Segments (2014)
Revenues & Net Income of Merck (2011-2014)
Pfizer’s Revenue Share by Operating Segments (2014)
Pfizer’s Revenues & Net Income (2011-2014)
The US Specialty Pharmaceutical Market (2014-2018E)

List of Tables

Specialty Pharmaceuticals - Key Application Areas
Specialty Pharmacy v/s Specialty Distributors
Key Players Providing Manufacturer Services
The US Specialty Pharmaceutical Market Constituents (TTM through 9/2014)
Specialty Pharmacy Market – by Value (2012-TTM)
Specialty Pharmaceutical Mergers and Acquisitions
Novel Products Launches in Key Specialty Areas
New Specialty/Biotech Product Launch Pipeline (2015-2018)
Leading 20 Specialty Drugs in the US by Company (2014 TTM)
Dependent & Independent Variables (2009–2014)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output

Note:  Purchase by Section Also Available

For more Information:

http://www.konceptanalytics.com/Researchreport/the-us-specialty-pharmaceutical-market-report-2015-edition-189.aspx

Koncept Analytics

Vikas Gupta

(Business Development Manager)

FFCS-36, Ansal Plaza

Vaishali, Ghaziabad

U.P - 201010

Tele: +91-120-4130959

Mobile: +91-9811715635

Mail ID – vikas@konceptanalytics.com

Koncept Analytics is a market research company. We are in the field of Market Research from last 10 Years. We do research in telecommunication, healthcare, pharmaceutical, financial services, energy, technology, real estate, logistics, food & beverages and media sectors. For more information:

http://www.konceptanalytics.com